Cargando…

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease

AIM: To determine the utility of the ultrasound‐guided attenuation parameter (UGAP) for quantifying hepatic steatosis in non‐alcoholic fatty liver disease (NAFLD). METHODS: Subjects were 84 patients with NAFLD (53 men, 31 women; mean age 54 [20–81] years) who underwent liver biopsy and ultrasonograp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogino, Yu, Wakui, Noritaka, Nagai, Hidenari, Igarashi, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341177/ https://www.ncbi.nlm.nih.gov/pubmed/34386604 http://dx.doi.org/10.1002/jgh3.12615

Ejemplares similares

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
por: Momiyama, Koichi, et al.
Publicado: (2015)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature
por: Matsui, Teppei, et al.
Publicado: (2022)

Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging
por: Wakui, Noritaka, et al.
Publicado: (2018)

Usefulness of virtual touch tissue quantification for predicting the presence of esophageal varices in patients with liver cirrhosis
por: Matsui, Teppei, et al.
Publicado: (2021)

Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver disease
por: Wakui, Noritaka, et al.
Publicado: (2018)

Arrival time parametric imaging of the hemodynamic balance changes between the hepatic artery and the portal vein during deep inspiration, using Sonazoid-enhanced ultrasonography: A case of Budd-Chiari syndrome
por: WAKUI, NORITAKA, et al.
Publicado: (2013)

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
por: Seo, Duck Min, et al.
Publicado: (2023)

Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?
por: Sirli, Roxana, et al.
Publicado: (2021)

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
por: Runge, Jurgen H., et al.
Publicado: (2020)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
por: Yoo, Jeong-Ju, et al.
Publicado: (2020)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
por: Song, Kyungchul, et al.
Publicado: (2022)

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
por: Nagai, Hidenari, et al.
Publicado: (2012)

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging
por: Rehman, Abdur, et al.
Publicado: (2022)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
por: Ferraioli, Giovanna
Publicado: (2021)

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
por: Yan, Yan, et al.
Publicado: (2020)

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
por: De Robertis, Riccardo, et al.
Publicado: (2023)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
por: Jeon, Sun Kyung, et al.
Publicado: (2021)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population
por: Khani, Vahid, et al.
Publicado: (2022)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis
por: Ren, Xinping, et al.
Publicado: (2022)

Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis
por: Matsukiyo, Yasushi, et al.
Publicado: (2018)

PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
por: Tong, Lei, et al.
Publicado: (2019)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis
por: Rónaszéki, Aladár D., et al.
Publicado: (2022)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet
por: Song, Lihua, et al.
Publicado: (2017)

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021)

The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients
por: Sirinawasatien, A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pmvn67oifao823uk5ba5rhnd9j